April 14, 2023 Lab Top-10

PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics

Introduction of a FFPE workflow extends the tissue proteomics applications of PreOmics’ unique BeatBox™ technology Launch of novel FFPE workflow enables high-throughput, robust and fast processing of tissue samples Bruker and PreOmics to co-commercialize BeatBox workflows ORLANDO, Fla.–(BUSINESS WIRE)– At the AACR Annual Meeting 2023, PreOmics GmbH announced the launch of a BeatBox-based FFPE workflow,... Read more

April 12, 2023 Lab Top-10 Licensing, IP, and Legal Liq. Handling & Robotics M&A, Partnerships

Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform

Enable Cloud Platform to be Available with Canopy CellScape System for High-Plex Spatial Biology ST. LOUIS & MENLO PARK, Calif.–(BUSINESS WIRE)– Canopy Biosciences, a Bruker Company, and Enable Medicine, today announced a partnership to provide Enable Medicine’s advanced analysis pipelines for spatial omics data with the Canopy CellScape™ system for quantitative high-plex spatial biology. The... Read more

April 10, 2023 Environ, Ag./Food & Bev Lab Top-10 PR/Corporate

Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock

Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock WASHINGTON, April 10, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its 5.00% Series B Mandatory Convertible Preferred Stock (the “Preferred Stock”), will automatically convert into shares of the Company’s common stock on April 17, 2023 (the “Conversion Date”). The conversion rate... Read more

March 27, 2023 Acad, Gov/Utilities Lab Top-10

Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies

WALTHAM, Mass. & SAN FRANCISCO–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s... Read more